|
|
May 27, 2010 by Administrator
|
“Sanofi-Aventis' $1.9 billion bid for OTC and personal care product firm Chattem offers the French firm a coveted toehold in the sizeable U.S. consumer health care market while also opening potential opportunities in emerging markets…”
click to read
|
|
May 25, 2010 by Administrator
|
“Lawsuits alleging that zinc in two popular denture creams damages nerves, combined with the recent recall of some zinc-containing Zicam products, could call into question the use of the mineral, which trade groups insist is safe when taken appropriately…”
click to read |
|
May 25, 2010 by Administrator
|
“FDA's announcement it is investigating a possible risk of liver injury related to orlistat - the active ingredient in Roche Pharmaceuticals' prescription weight-loss drug Xenical and GlaxoSmithKline's OTC Alli - could threaten short-term sales…”
click to read |
|
May 18, 2010 by Administrator
|
“Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player…”
click to read
|
|
|
|
|
The Tan Sheet
All content items
